Related Experiment Video

Updated: Jun 3, 2026

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression

Sangho Lee1, Hayeong Kwon, Kyuho Jeong

  • 1Department of Biochemistry, Division of Applied Life Science (BK21), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju 660-701, Republic of Korea.

International Journal of Oncology
|March 5, 2011
PubMed

Insights

Altering caveolin-2 (cav-2) expression impacts cancer cell proliferation. Cav-2 can inhibit or promote cancer growth depending on the cell type, suggesting it modulates cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Caveolin-2 (cav-2) is a protein involved in cellular processes.
  • Its role in cancer progression is not fully understood.
  • Cav-2 expression varies across different cancer cell lines.

Purpose of the Study:

  • To investigate the effect of altering caveolin-2 (cav-2) expression on cancer cell proliferation.
  • To determine if cav-2 acts as an oncogene or tumor suppressor.
  • To explore the mechanisms by which cav-2 influences cancer growth.

Main Methods:

  • Assessing cav-2 expression in various cancer cell lines (HepG2, SH-SY5Y, LN-CaP, C6, HeLa, A549, MCF7, PC3M).
  • Manipulating cav-2 expression via transfection (re-expression) and siRNA (knockdown).
  • Evaluating cancer cell proliferation using MTT assays, colony formation assays, and flow cytometry.
  • Analyzing transcriptional activity of Elk-1 and STAT3 using luciferase reporter assays.

Main Results:

  • Cav-2 expression was absent in HepG2, SH-SY5Y, and LN-CaP cells, and unaffected by 5-aza-2'-deoxycytidine treatment.
  • Cav-2 expression was detected in C6, HeLa, A549, MCF7, and PC3M cells.
  • Cav-2 re-expression in HepG2 cells and knockdown in C6 cells reduced proliferation and S-phase entry.
  • Cav-2 re-expression in SH-SY5Y cells and knockdown in HeLa and A549 cells promoted proliferation.
  • Transcriptional activation of Elk-1 and STAT3 decreased in cav-2-transfected HepG2 and down-regulated C6 cells.

Conclusions:

  • Caveolin-2 (cav-2) plays a dual role in cancer progression, acting as a suppressor in some cancers and a promoter in others.
  • The effect of cav-2 on proliferation is cell-type dependent.
  • Cav-2 influences cancer progression potentially through modulation of Elk-1 and STAT3 signaling pathways.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...